Back in October, we discussed allegations that the large pharmacy chain, CVS, had been refilling prescriptions without customer approval and fraudulently billing their insurance companies without customer approval. California was a leader in this investigation, with the federal government joining in because of Medicare fraud concerns. Now, a case is pending against another pharmacy company, suggesting a disturbing pattern of pharmaceutical fraud that is of great concern to our San Francisco fraudulent prescriptions lawyer.
An Overview of PharMerica and the Fraud Litigation
PharMerica calls itself, “a leader in long term care pharmacy service.” In simple terms, the company manages pharmacy services in long-term care, assisted-living and other institutional health care settings, dispensing medicines to residents in such settings. According to Reuters, in the 2007-2009 timeframe, PharMerica provided pharmacy services to around 300,000 residents and filled approximately 40 million prescriptions per year. During that time frame, Medicare’s prescription program, Part D, provided 45% of PharMerica’s prescription drug revenue during the time at issue.